Loading organizations...
Loading organizations...
Biopharmaceutical company developing therapies for CNS disorders.
Praxis Precision Medicines has raised $210.0M across 2 funding rounds.
Praxis Precision Medicines has raised $210.0M in total across 2 funding rounds.
Praxis Precision Medicines has raised $210.0M in total across 2 funding rounds.
Praxis Precision Medicines's investors include Finny Kuruvilla, Adage Capital Management, Avoro Capital Advisors, Blackstone, Cormorant Asset Management, Irving Investors, Novo Holdings, OCV Partners, Point72, Qatar Investment Authority, Surveyor Capital, Verition Fund Management.
Praxis Precision Medicines has raised $210.0M across 2 funding rounds. Most recently, it raised $110.0M Series C in July 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 28, 2020 | $110.0M Series C | Finny Kuruvilla | Adage Capital Management, Avoro Capital Advisors, Blackstone, Cormorant Asset Management, Irving Investors, Novo Holdings, OCV Partners, Point72, Qatar Investment Authority, Surveyor Capital, Verition Fund Management, Vida Ventures |
| May 4, 2020 | $100.0M Other Equity | Kiran Reddy | Eventide Asset Management, Novo Holdings, Vida Ventures |